Literature DB >> 2397920

Oxygen radical injury and loss of high-energy compounds in anoxic and reperfused rat heart: prevention by exogenous fructose-1,6-bisphosphate.

B Tavazzi1, L Cerroni, D Di Pierro, G Lazzarino, M Nuutinen, J W Starnes, B Giardina.   

Abstract

Isolated Langendorff-perfused rat hearts after 10 minutes preperfusion, were subjected to a substrate-free anoxic perfusion (20 minutes) followed by 20 minutes reperfusion with a glucose-containing oxygen-balanced medium. Under the same perfusion conditions, the effect of exogenous 5mM fructose-1,6-bisphosphate has been investigated. The xanthine dehydrogenase to xanthine oxidase ratio, concentrations of high-energy phosphates and of TBA-reactive material (TBARS) were determined at the end of each perfusion period in both control and fructose-1,6-bisphosphate-treated hearts. Results indicate that anoxia induces the irreversible transformation of xanthine dehydrogenase into oxidase as a consequence of the sharp decrease of the myocardial energy metabolism. This finding is supported by the protective effect exerted by exogenous fructose-1,6-bisphosphate which is able to maintain the correct xanthine dehydrogenase/oxidase ratio by preventing the depletion of phosphorylated compounds during anoxia. Moreover, in control hearts, the release of lactate dehydrogenase during reperfusion, is paralleled by a 50% increase in the concentration of tissue TBARS. On the contrary, in fructose-1,6-bisphosphate-treated hearts this concentration does not significantly change after reoxygenation, while a slight but significant increase of lactate dehydrogenase activity in the perfusates is observed. On the whole these data indicate a direct contribution of oxygen-derived free radicals to the worsening of post-anoxic hearts. A hypothesis on the mechanism of action of fructose-1,6-bisphosphate in anoxic and reperfused rat heart and its possible application in the clinical therapy of myocardial infarction are presented.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2397920     DOI: 10.3109/10715769009149885

Source DB:  PubMed          Journal:  Free Radic Res Commun        ISSN: 8755-0199


  8 in total

1.  Malondialdehyde is a biochemical marker of peroxidative damage in the isolated reperfused rat heart.

Authors:  D Di Pierro; B Tavazzi; G Lazzarino; B Giardina
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

2.  Transport and metabolism of exogenous fumarate and 3-phosphoglycerate in vascular smooth muscle.

Authors:  D R Finder; C D Hardin
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

3.  Fructose-1,6-bisphosphate as a metabolic substrate in hog ileum smooth muscle during hypoxia.

Authors:  T M Juergens; C D Hardin
Journal:  Mol Cell Biochem       Date:  1996-01-12       Impact factor: 3.396

4.  Energy metabolism in hypoxic astrocytes: protective mechanism of fructose-1,6-bisphosphate.

Authors:  J A Kelleher; P H Chan; T Y Chan; G A Gregory
Journal:  Neurochem Res       Date:  1995-07       Impact factor: 3.996

5.  Exogenous fructose-1,6-bisphosphate is a metabolizable substrate for the isolated normoxic rat heart.

Authors:  B Tavazzi; J W Starnes; G Lazzarino; D Di Pierro; E M Nuutinen; B Giardina
Journal:  Basic Res Cardiol       Date:  1992 May-Jun       Impact factor: 17.165

Review 6.  Current state of hypothermic machine perfusion preservation of organs: The clinical perspective.

Authors:  Michael J Taylor; Simona C Baicu
Journal:  Cryobiology       Date:  2009-10-24       Impact factor: 2.487

7.  The relevance of malondialdehyde as a biochemical index of lipid peroxidation of postischemic tissues in the rat and human beings.

Authors:  G Lazzarino; B Tavazzi; D Di Pierro; R Vagnozzi; M Penco; B Giardina
Journal:  Biol Trace Elem Res       Date:  1995 Jan-Mar       Impact factor: 3.738

8.  Fructose-1,6-Bisphosphate Protects Hippocampal Rat Slices from NMDA Excitotoxicity.

Authors:  Kamal M Yakoub; Giacomo Lazzarino; Angela M Amorini; Giuseppe Caruso; Concetta Scazzone; Marcello Ciaccio; Barbara Tavazzi; Giuseppe Lazzarino; Antonio Belli; Valentina Di Pietro
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.